iPLEDGE REMS Explained: What It Is and the Rules by Patient Group
Quick answer: iPLEDGE is the FDA safety program, called a REMS, that governs every isotretinoin prescription. The FDA calls it a shared system that includes all FDA-approved isotretinoin products. It exists because the Accutane label warns of an extremely high risk of life-threatening birth defects if pregnancy occurs while taking the drug. What you do depends on your group: patients who can get pregnant have tests and monthly questions, and patients who cannot get pregnant have a lighter path. This page is current as of October 14, 2026.
The rules below come from the FDA, the Accutane label on DailyMed and MedlinePlus. Several rules are planned to change on November 15, 2026, and we date every one of those so you can tell what applies today.
What is iPLEDGE REMS and why does it exist?
REMS stands for Risk Evaluation and Mitigation Strategy. It is a program the FDA requires for a drug whose risks need controls beyond the label. The FDA’s iPLEDGE page describes it as a shared system covering every FDA-approved isotretinoin product, so brand and generic versions all follow the same program.
The reason for all of it is pregnancy risk. The Accutane Medication Guide describes an extremely high risk of life-threatening birth defects if pregnancy occurs while taking Accutane. That risk applies in any amount, even for short periods of time. MedlinePlus adds a high risk of pregnancy loss, premature birth, or a baby who dies shortly after birth.
So iPLEDGE links the patient, the prescriber and the pharmacy. Your prescriber enrolls you, your pharmacy must be enrolled, and the pharmacist contacts the system for an authorization before filling each prescription. The label says Accutane must only be dispensed after authorization from the iPLEDGE REMS, in no more than a 30-day supply, and with a new prescription for each refill.
What does every isotretinoin patient have to do?
Some rules apply to all patients, and your group does not change them. The MedlinePlus isotretinoin page says all patients can get isotretinoin only if they are registered with iPLEDGE. They also need a prescription from a registered doctor and a registered pharmacy. It also says not to buy isotretinoin over the internet.
The label lists the other shared conditions.
Per the label, your prescriber enrolls you in iPLEDGE, and you sign a patient enrollment form. You do not donate blood while on isotretinoin or for one month after treatment ends. You do not share isotretinoin with anyone, even someone with similar symptoms. You also see your prescriber every month for a new prescription, which is a supply of up to 30 days with no refills.
The Medication Guide says your doctor gives you an identification number and card when treatment starts, and you need that number to fill your prescriptions. Our iPLEDGE program explainer covers the same program in more detail.
What are the rules for patients who can get pregnant?
This group has the most steps, because the program exists to prevent pregnancy exposure. The label sets these requirements for patients who can become pregnant:
- Two negative pregnancy tests before the first prescription, with a sensitivity of at least 25 mIU/mL.
- The second test is a confirmation test done in a CLIA-certified laboratory, at least 19 days after the first.
- Two separate forms of effective birth control at once, from one month before until one month after Accutane. The label lists exceptions, such as continuous abstinence.
- Contact with the iPLEDGE system before starting, monthly during therapy and one month after the last dose. You answer program questions and enter your two chosen forms of contraception.
The Medication Guide says you can only keep getting isotretinoin after the monthly contact and a doctor visit. You also need a negative pregnancy test within the past 7 days. The REMS safe-use conditions also say not to get pregnant, and the label’s two-birth-control rule runs from one month before to one month after treatment.
How long do you have to pick up the prescription?
The label says patients who can become pregnant must obtain the prescription within 7 days of the date of specimen collection for the pregnancy test. The clock starts at the sample date, not the result date. Today, if you miss that first window before treatment starts, you must wait 19 days before the repeat test, under the lockout. The approved REMS document says the same about the authorization being valid for 7 days from that date.
Our article on prescription window timing for each group goes through the clock step by step. If a window closes, see what happens after a missed iPLEDGE window.
What are the rules for patients who cannot get pregnant?
MedlinePlus places men and women who cannot become pregnant in this group. The FDA says health care providers assign and confirm each patient’s risk category, so confirm yours with your prescriber.
The group has a short list of patient steps. The approved REMS document lists counseling from your prescriber on the risks and REMS requirements. You also review the Guide for Patients Who Cannot Get Pregnant and enroll by completing the matching Patient Enrollment Form. After that, the safe use conditions are not donating blood and not sharing isotretinoin.
The label‘s monthly table marks the patient questions and contraception entries only for patients who can become pregnant. So a patient who cannot get pregnant has no monthly pregnancy test, and the label lists no monthly attestation for this group.
Today the pickup window for this group is longer. The label says patients who cannot become pregnant must obtain the prescription within 30 days of the office visit. For male patients, the Medication Guide says a very small amount of isotretinoin will probably be present in semen. It is not known if that amount may harm the fetus if a partner is or becomes pregnant. Tell your doctor if a partner is pregnant, plans to become pregnant or becomes pregnant during treatment.
For more on this group, our post on Accutane for men explains how the monthly course works.
What do prescribers and pharmacists do?
Your prescriber and pharmacist carry the rest of the system. The approved REMS document has prescribers assess the patient’s current reproductive status before each prescription during treatment, and prescribe no more than a 30-day supply with no refills.
In the REMS document, for patients who cannot get pregnant, pharmacies contact the REMS for authorization to dispense each prescription. That check verifies the prescriber is certified and the patient is enrolled. Patients who can get pregnant have the additional steps described above. The same document says pharmacies must not dispense more than a 30-day supply and must not dispense refills. The label adds that a pharmacist can reach the system through the iPLEDGE website or by phone at 1-866-495-0654.
If the pickup deadline passes, the label says the authorization must be reversed in the iPLEDGE system and the product returned to inventory. What happens next differs by group. For a patient who can get pregnant who has not started treatment, the next step today is a repeat pregnancy test after the 19-day lockout.
Can you use a home pregnancy test with iPLEDGE?
For patients who can get pregnant, this applies today, not on November 15. The FDA says it will continue to exercise enforcement discretion on pregnancy testing, as described in its October 2023 update. Under that update, the FDA does not intend to object if prescribers rely on home pregnancy tests. The patient performs them and reports the dates and results during and after isotretinoin treatment.
The same update says all pre-treatment pregnancy tests must be performed in a medical setting, such as an office or laboratory. Our iPledge FAQ says that for a telehealth patient, a medical setting means a lab. The update also says prescribers remain responsible for interpreting and documenting every result in the iPLEDGE system. Prescribers who rely on home tests need to take steps to minimize patients falsifying results.
The label still says a pregnancy test must be repeated every month in a CLIA-certified laboratory. Because of the FDA’s enforcement discretion, a prescriber may accept home tests during treatment. Whether yours does is your prescriber’s decision. Our article on how to get Accutane prescribed explains the steps before your first prescription.
What changes are planned for November 15, 2026?
The changes in this section are not in effect as of October 14, 2026. The FDA approved modifications to the iPLEDGE REMS on February 9, 2026. The agency first scheduled them for August 8, 2026, then moved the planned date to November 15, 2026. Because the date has already slipped once, check the FDA page for the current status.
If the planned changes take effect, they include the items below. Until then, the rules in the sections above still apply.
Per the FDA page, the 30-day prescription window for patients who cannot get pregnant will end. If a patient who can get pregnant misses the 7-day window, a repeat pregnancy test may be done right away, with no added waiting period. Today, the 19-day lockout applies only if a patient who can get pregnant misses the first 7-day window, before treatment starts. The planned change removes that wait. If that patient has not received a first dose, the repeat test must be done in a medical setting. Patients who cannot get pregnant must be counseled at enrollment, and prescribers should reinforce counseling throughout treatment. Monthly documentation of that counseling in the REMS will no longer be required.
Pre-treatment pregnancy tests stay in a medical setting both now and after November 15. The FDA page says patients may complete pregnancy tests outside a medical setting during and after treatment if the prescriber permits. Pre-treatment tests stay in a medical setting. Home tests are not a November 15 change.
How do you log in or get help with iPLEDGE?
After your prescriber enrolls you, the iPLEDGE patient troubleshooting tips say you will receive an email with an invitation link to set your username and password. If you forget either, use the “Forgot Username?” or “Forgot password?” link on the iPLEDGE website.
If no reset email arrives, the same tips say to check that the address is active and spelled correctly, and to look in your spam or junk folder. If it still does not arrive, the information you are using may not match what is on file with the REMS. The tips say to contact the Contact Center then. The tips do not cover being locked out, so ask the Contact Center or your prescriber.
The Medication Guide gives the iPLEDGE REMS phone number as 1-866-495-0654 and the website as ipledgeprogram.com. Patients who can get pregnant use the same system for the monthly questions described above.
Common questions about iPLEDGE REMS
Does everyone have to do monthly pregnancy tests? No, because the label ties the monthly pregnancy test and patient questions to patients who can become pregnant. Patients who cannot get pregnant still see their prescriber each month to get a new prescription.
How long do I have to pick up my prescription? As of October 14, 2026, it is 7 days from the pregnancy test specimen collection date if you can get pregnant. If you cannot get pregnant, it is 30 days from the office visit, and the FDA plans to remove that window on November 15, 2026.
Can I take a home pregnancy test instead of going to a lab? During and after treatment, the FDA’s October 2023 enforcement discretion lets prescribers rely on patient-reported home tests, and it is your prescriber’s call. All pre-treatment tests must be done in a medical setting.
Do the November 15, 2026 changes apply now? No, they are not in effect as of October 14, 2026, because November 15 has not arrived. The FDA approved them on February 9, 2026 and planned implementation for November 15, 2026, so check the FDA page for the current status.
Who actually runs the iPLEDGE program? The FDA requires the REMS, and it is a shared system covering all FDA-approved isotretinoin products. You interact with it through your prescriber, your pharmacist and the iPLEDGE website or phone line.
What should you do before your next visit?
Ask your prescriber which group you are in and when your next window opens. Write down your identification number, and keep the iPLEDGE phone number from your Medication Guide. If your course crosses November 15, 2026, ask what changes for your next fill.
If you want a board-certified dermatologist to look at your acne, take the quiz, which takes about two minutes. Accutane Care at The Goal Is Clear includes an iPledge concierge that tracks every window, test and refill. You can read our iPledge FAQ and our Accutane cost FAQ, and see pricing, where the cost is as low as $0 for the prescription with insurance. Our guides to iPledge requirements by group, generic versus brand and side effects cover the rest of the course.
This article is general information, not medical advice. A prescription is never guaranteed, and treatment decisions stay with the board-certified dermatologist who reviews your case. Accutane® is a registered trademark of its respective owner, and isotretinoin is the generic name. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician. Independent board-certified dermatologists prescribe the medication.
Sources
General information from published sources, not medical advice. Your dermatologist makes every treatment decision after reviewing your case. The Goal Is Clear is operated by BNG Health Services, LLC, which is not the prescribing physician.
← Blog Home